Endo-1,4-beta-xylanase

BE0003071ProteinBacillus circulansxlnA

Endo-1,4-beta-xylanase (Bacillus circulans) is a protein target in DrugBank. It is acted on by 1 drug in DrugBank.

Gene name
xlnA
UniProtKB entry
P09850Swiss-Prot
Cellular location
Cytoplasmic
Residues / weight
213 residues · 23,359 Da
Also known as
1,4-beta-D-xylan xylanohydrolase · 3.2.1.8 · Xylanase

Resolves to

Protein
UniProtP09850UniProt nameXYNA_NIACI
Structure
PDB1BCXPDB1BVVPDB1C5H
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Endo-1,4-beta-xylanase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In